Literature DB >> 34283284

Comparative Study of ESBL Production Among Uropathogenic Escherichia coli Clinical Isolates from Pre- and Post-menopausal Women in Egypt.

Ghada Hani Ali1, Marwa A Yakout2.   

Abstract

Urinary tract infection (UTI) is regarded one of the most frequent bacterial infections in women. Accordingly, the aim of the current study was to determine the prevalence of extended-spectrum beta-lactamase (ESBL), as well as the degree of antimicrobial resistance among premenopausal (n = 44) and postmenopausal (n = 49) women suffering from uncomplicated UTI. Urinary samples (n = 93) collected from women with UTI were tested for their antimicrobial sensitivity and assessed for ESBL production by both phenotypic and genotypic methods. Phenotypically, the presence of ESBL was observed in 64 isolates, while polymerase chain reaction detected ESBL-encoding genes in 57 isolates. The CTX-M gene was the most predominant (51.6%), followed by TEM (46.2%), and the SHV gene (17.2%). Surprisingly, all ESBL-producing Escherichia coli isolates were multidrug-resistant (MDR). To the best of our knowledge, this is the first study conducted in Egypt showing significant correlation between ESBL production, multidrug resistance and menopausal state in women. The results demonstrate alarming signal for the dissemination of ESBL genes among uropathogenic E. coli that are MDR in Egypt.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Year:  2021        PMID: 34283284     DOI: 10.1007/s00284-021-02599-2

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  41 in total

Review 1.  Pathogens resistant to antibacterial agents.

Authors:  Luke F Chen; Teena Chopra; Keith S Kaye
Journal:  Infect Dis Clin North Am       Date:  2009-12       Impact factor: 5.982

2.  Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment.

Authors:  Sibhghatulla Shaikh; Jamale Fatima; Shazi Shakil; Syed Mohd Danish Rizvi; Mohammad Amjad Kamal
Journal:  Saudi J Biol Sci       Date:  2014-08-17       Impact factor: 4.219

3.  Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.

Authors:  S Meier; R Weber; R Zbinden; C Ruef; B Hasse
Journal:  Infection       Date:  2011-06-25       Impact factor: 3.553

Review 4.  Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden.

Authors:  Betsy Foxman
Journal:  Infect Dis Clin North Am       Date:  2013-12-08       Impact factor: 5.982

5.  Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel.

Authors:  Kevin B Laupland; Deirdre L Church; Jeanne Vidakovich; Melissa Mucenski; Johann D D Pitout
Journal:  J Infect       Date:  2008-11-05       Impact factor: 6.072

6.  Effects of a new combination of  plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections.

Authors:  Carlo Genovese; Sergio Davinelli; Katia Mangano; Gianna Tempera; Daria Nicolosi; Salvatore Corsello; Franca Vergalito; Edoardo Tartaglia; Giovanni Scapagnini; Roberto Di Marco
Journal:  J Chemother       Date:  2017-10-27       Impact factor: 1.714

7.  Antimicrobial Resistance Patterns in Women with Positive Urine Culture: Does Menopausal Status Make a Significant Difference?

Authors:  Pawel Miotla; Katarzyna Romanek-Piva; Michal Bogusiewicz; Ewa Markut-Miotla; Aneta Adamiak; Andrzej Wróbel; Małgorzata Zebrowska; Sara Wawrysiuk; Katarzyna Mendyk; Ewa Rechberger; Agata Jakubczak; Tomasz Rechberger
Journal:  Biomed Res Int       Date:  2017-04-13       Impact factor: 3.411

8.  Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand.

Authors:  Jiranun Bubpamala; Piyatip Khuntayaporn; Krit Thirapanmethee; Preecha Montakantikul; Pitak Santanirand; Mullika T Chomnawang
Journal:  Infect Drug Resist       Date:  2018-11-05       Impact factor: 4.003

Review 9.  Extended Spectrum Beta-lactamases: Definition, Classification and Epidemiology.

Authors:  Sobhan Ghafourian; Nourkhoda Sadeghifard; Sara Soheili; Zamberi Sekawi
Journal:  Curr Issues Mol Biol       Date:  2014-05-12       Impact factor: 2.081

10.  Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.

Authors:  Sakina Fatima; Iyad Neeam Muhammad; Shahnaz Usman; Subia Jamil; Muhammad Naseem Khan; Seema Ismat Khan
Journal:  Indian J Pharmacol       Date:  2018 Mar-Apr       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.